SPECTRUM PHARMACEUTICALS INC
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | |
|---|---|---|---|---|---|---|
| Revenue | $10.1M | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$72.7M | −$147.7M | −$169.7M | −$37.8M | −$30.0M | −$116.3M |
| Net income | −$75.4M | −$158.6M | −$160.9M | −$112.7M | −$19.2M | −$92.2M |
| Total assets | $103.3M | $111.5M | $196.8M | $263.4M | $390.9M | $487.4M |
| Total liabilities | $75.5M | $64.0M | $62.6M | $73.0M | $119.5M | $136.1M |
| Equity | $27.9M | $47.6M | $134.2M | $190.4M | $271.4M | $351.3M |
| EPS (diluted) | $-0.41 | $-1.02 | $-1.29 | — | $-1.16 | $-1.07 |
| Shares out. | 177.2M | 153.7M | 113.7M | 111.0M | 102.7M | 80.3M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2022- Operating margin
- −718.8%
- Net margin
- −745.5%
- Return on equity
- −270.4%
- Return on assets
- −73.0%
- Return on capital (ROCE)
- −119.9%
- Liabilities / assets
- 73.0%
- Debt / equity
- 2.71×
- Book value / share
- $0.16
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2022- Altman Z″ (distress)
- -35.95distress
- Accruals / assets
- 20.9%high accruals
- Piotroski F-Score
- 3/8weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 5 warning● 0 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- High accruals — earnings-quality risk
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-K/Amissed a reporting deadline ↗May 1, 2018
- NT 10-Qmissed a reporting deadline ↗Nov 10, 2016
- NT 10-Qmissed a reporting deadline ↗Nov 12, 2013
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Clinical trials
ClinicalTrials.gov · ongoing · next readout firstInterventional studies led by this company. “Readout” is the trial's primary-completion date — an estimate the sponsor reports, not a guarantee.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylaws · Other material eventAug 1, 2023
- Shareholder vote · Other material eventJul 27, 2023
- Other material eventMay 17, 2023
- Results of operationsMay 9, 2023
- Director / officer changeMay 1, 2023
- Entered a material agreement · Other material eventApr 25, 2023
- Amended charter or bylawsApr 4, 2023
- Director / officer changeApr 3, 2023
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.